1. Huang, L., Zhu, Q., Qu, X., and Qin, H. (2018). Microbial treatment in chronic constipation. Sci China Life Sci in press doi: 10.1007/s11427-017-9220-7.
2. Li, F., Sun, G., Wang, Z., Wu, W., Guo, H., Peng, L., Wu, L., Guo, X., and Yang, Y. (2018). Characteristics of fecal microbiota in non-alcoholic fatty liver disease patients. Sci China Life Sci in press doi: 10.1007/ s11427-017-9303-9.
3. Li, M., Wu, Y., Hu, Y., Zhao, L., and Zhang, C. (2017). Initial gut microbiota structure affects sensitivity to DSS-induced colitis in a mouse model. Sci China Life Sci in press doi: 10.1007/s11427-017-9097-0.
4. Li, Z.Z., Xue, J., Chen, P., Chen, L.Z., Yan, S.P., and Liu, L.Y. (2014). Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies. J Gastroenterol Hepatol 29, 42–51.
5. McGonigle, P., and Ruggeri, B. (2014). Animal models of human disease: challenges in enabling translation. Biochem Pharmacol 87, 162–171.